ArticlePeerJ2026
Association between perceived stigma and satisfaction with diabetes technologies among adolescents and young adults with type 1 diabetes: a cross-sectional study in Turkey.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: There was no clinical evidence regarding the relationship between stigmatization and satisfaction with diabetes technologies in persons with type 1 diabetes. The aim of this cross-sectional study is to examine the association between perceived stigma and satisfaction with diabetes technologies among adolescents and young adults living with type 1 diabetes. Materials and Methods: This descriptive and correlational study was conducted in three hospitals of Turkey between July 4, 2022, and March 1, 2023. The study sample consisted of 150 persons with type 1 diabetes aged 12-22 who attended these hospitals. Data were collected using the "Patient Information Form," "Diabetes Technology Questionnaire (DTQ)," and "Type 1 Diabetes Stigma Assessment Scale (DSAS-1)." Results: The disease-related characteristics of the participants were examined. It was found that 92% used an insulin pen, 90.6% used a glucometer for glucose measurement, 57.4% measured glucose in public places such as buses and cafes, and 33.8% experienced discrimination in public while measuring glucose. Additionally, 52.7% experienced hyperglycemia, 44.7% experienced hypoglycemia, and 10.7% had a chronic disease. In multiple regression analyses, higher perceived stigma (DSAS-1 total; standardized Conclusions: As DTQ scores increased, the DSAS-1 total scores decreased. Improving access to diabetes technologies for individuals with type 1 diabetes should be prioritized. Additionally, randomized controlled studies could be conducted to further explore the impact of diabetes technologies on perceived stigma in people with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.